Cargando…
New ways of assessing ovarian cancer response: metabolic imaging and beyond
In patients with advanced ovarian cancer, it can be challenging to evaluate response to neoadjuvant chemotherapy on computed tomography (CT) due to disseminated small volume disease and serosal disease. In addition, measuring the change in size of tumour burden takes time in order to allow tumour sh...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
e-Med
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460555/ https://www.ncbi.nlm.nih.gov/pubmed/23022953 http://dx.doi.org/10.1102/1470-7330.2012.9004 |